Oracle Investment Management Inc buys $39,374,840 stake in O
Sept 9, 2016 23:28:53 GMT
miamianne67, thought013, and 1 more like this
Post by Deleted on Sept 9, 2016 23:28:53 GMT
(OPK)
Opko Health (OPK) : Oracle Investment Management Inc scooped up 200 additional shares in Opko Health during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 15, 2016. The investment management firm now holds a total of 3,914,000 shares of Opko Health which is valued at $39,374,840.Opko Health makes up approximately 7.20% of Oracle Investment Management Inc’s portfolio.
Other Hedge Funds, Including , Marathon Capital Management added OPK to its portfolio by purchasing 15,000 company shares during the most recent quarter which is valued at $150,900. Opko Health makes up approx 0.08% of Marathon Capital Management’s portfolio.Essex Investment Management Co boosted its stake in OPK in the latest quarter, The investment management firm added 41,607 additional shares and now holds a total of 377,496 shares of Opko Health which is valued at $3,756,085. Opko Health makes up approx 0.60% of Essex Investment Management Co’s portfolio.
Opko Health opened for trading at $9.31 and hit $9.54 on the upside on Thursday, eventually ending the session at $9.29, with a gain of 2.09% or 0.19 points. The heightened volatility saw the trading volume jump to 35,15,257 shares. Company has a market cap of $5,113 M.
On the company’s financial health, Opko Health reported $0.02 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Aug 8, 2016. Analyst had a consensus of $-0.03. The company had revenue of $357.10 million for the quarter, compared to analysts expectations of $324.11 million. The company’s revenue was up 742.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.09 EPS.
Many Wall Street Analysts have commented on Opko Health. Company shares were Reiterated by Standpoint Research on Jun 21, 2016 to “Buy”, Firm has raised the Price Target to $ 18 from a previous price target of $16 .Standpoint Research Initiated Opko Health on Jun 3, 2016 to “Buy”, Price Target of the shares are set at $16.
Opko Health (OPK) : Oracle Investment Management Inc scooped up 200 additional shares in Opko Health during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 15, 2016. The investment management firm now holds a total of 3,914,000 shares of Opko Health which is valued at $39,374,840.Opko Health makes up approximately 7.20% of Oracle Investment Management Inc’s portfolio.
Other Hedge Funds, Including , Marathon Capital Management added OPK to its portfolio by purchasing 15,000 company shares during the most recent quarter which is valued at $150,900. Opko Health makes up approx 0.08% of Marathon Capital Management’s portfolio.Essex Investment Management Co boosted its stake in OPK in the latest quarter, The investment management firm added 41,607 additional shares and now holds a total of 377,496 shares of Opko Health which is valued at $3,756,085. Opko Health makes up approx 0.60% of Essex Investment Management Co’s portfolio.
Opko Health opened for trading at $9.31 and hit $9.54 on the upside on Thursday, eventually ending the session at $9.29, with a gain of 2.09% or 0.19 points. The heightened volatility saw the trading volume jump to 35,15,257 shares. Company has a market cap of $5,113 M.
On the company’s financial health, Opko Health reported $0.02 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Aug 8, 2016. Analyst had a consensus of $-0.03. The company had revenue of $357.10 million for the quarter, compared to analysts expectations of $324.11 million. The company’s revenue was up 742.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.09 EPS.
Many Wall Street Analysts have commented on Opko Health. Company shares were Reiterated by Standpoint Research on Jun 21, 2016 to “Buy”, Firm has raised the Price Target to $ 18 from a previous price target of $16 .Standpoint Research Initiated Opko Health on Jun 3, 2016 to “Buy”, Price Target of the shares are set at $16.
